Records containing: Positron-Emission Tomography
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-07-28Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging in Detecting Metastatic Central Lymph Nodes in Patients With Papillary Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2022-06-27Comparison of Positron Nuclide Labeled DOTA-FAPI PET and FDG PET Study in Colocrectal Cancer
-
CLINICAL_TRIALS study record update · 2022-06-09Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in Lymphoma
-
CLINICAL_TRIALS study record update · 2022-04-28Correlazione Dell'Imaging Metabolico Con l'Espressione Dei Marcatori Immunitari Nei Pazienti Con NSCLC Candidati All'Immunoterapia.
-
CLINICAL_TRIALS study record update · 2022-04-25Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-02-22Dynamic Wholebody FDG PET/CT - Next Generational Functional Imaging: Optimization and Validation of Data Acquisition
-
CLINICAL_TRIALS study record update · 2021-02-26Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI
-
CLINICAL_TRIALS study record update · 2020-09-09A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity
-
CLINICAL_TRIALS study record update · 2020-09-0968Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
-
CLINICAL_TRIALS study record update · 2020-09-0968Ga-DOTA/NOTA-FAPI-04 PET/CT in Patients With Various Types of Cancer
-
CLINICAL_TRIALS study record update · 2020-04-29Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma
-
CLINICAL_TRIALS study record update · 2020-04-09Molecular Imaging of Brain Inflammation in Depressive Disorders
-
CLINICAL_TRIALS study record update · 2019-05-0618FluoroDeoxyGlucose-Positron Emission Tomography (PET) in Patients With Melanoma or Non Small Cell Lung Cancer Treated With Immunotherapy
-
CLINICAL_TRIALS study record update · 2019-03-28The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents
-
CLINICAL_TRIALS study record update · 2018-09-18A Phase I Study of Positron Emission Tomography (PET/CT) With ⁸⁹Zr-Df-IAB22M2C in Patients With Selected Solid Malignancies (Non Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Squamous Cell Carcinoma Head and Neck (SqCCHN), Melanoma, Merkel Cell Tumor, Renal, Bladder, Hepatocellular, Triple Negative Breast, or Gastroesophageal Cancer) or Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2016-11-23Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies in Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2016-09-29Role of Fluorodeoxyglucose (FDG) PET-CT in the Initial Staging of Breast Cancer (ASAINT 1) and in the Early Assessment of Response to Neoadjuvant Chemotherapy (ASAINT 2)
-
CLINICAL_TRIALS study record update · 2015-01-08Open-label, Non-randomized, Positron Emission Tomography (PET) Imaging Study to Evaluate a Single Dose of 250 MBq (6.75 mCi) ZK 6032924 (18F-FEDAA1106) for Its Diagnostic Potential in Discriminating Patients With Probable Alzheimer's Disease From Healthy Volunteers and to Evaluate the Radiation Dosimetry of a Single Dose of 185 MBq (5 mCi) ZK 6032924 in Healthy Volunteers.
-
CLINICAL_TRIALS study record update · 2014-04-02Open-label, Non-randomized, Positron Emission Tomography (PET) Imaging Study to Evaluate a Single Dose of 140 MBq (ca. 5 mSv) ZK 6032924 (BAY85-8101) for Its Diagnostic Potential in Either Drug-naïve or Specifically (IFN-beta) Pretreated Patients With Multiple Sclerosis (MS) With Acute Relapse or Patients With Clinically Isolated Syndrome (CIS), Compared to Healthy Volunteers